Results 251 to 260 of about 17,151,553 (293)
Some of the next articles are maybe not open access.

IBS-D

2023
W. Harley Sobin, Patrick Sanvanson
openaire   +1 more source

Sa607 A PHASE II STUDY OF LIVE BIOTHERAPEUTIC BLAUTIX IN IRRITABLE BOWEL SYNDROME (IBS) PATIENTS WITH SUBTYPES IBS-D AND IBS-D

Gastroenterology, 2021
Alex Stevenson   +4 more
openaire   +1 more source

Ramosetron Is Effective in Women With IBS-D

MD Conference Express, 2015
L. Lederman, S. Fukudo
openaire   +1 more source

An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-D.

Gastroenterology & hepatology, 2014
Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder and affects up to 12% to 15% of adults in the United States, with a higher prevalence among women and those younger than 50 years. IBS adversely impacts quality of life and medical expenditures, with significant costs arising from healthcare visits and reduced ...
Brian E, Lacy   +2 more
openaire   +1 more source

Safety of Eluxadoline in Patients With IBS-D Without a Gallbladder

American Journal of Gastroenterology, 2017
Brooks D, Cash   +4 more
openaire   +2 more sources

Comparison Chart: Some Drugs for Irritable Bowel Syndrome with Diarrhea (IBS-D)

The Medical Letter on Drugs and Therapeutics
Comparison Chart: Some Drugs for Irritable Bowel Syndrome with Diarrhea (IBS-D)
openaire   +2 more sources

Home - About - Disclaimer - Privacy